Filing Details
- Accession Number:
- 0001209191-18-023804
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-04 17:18:58
- Reporting Period:
- 2018-04-02
- Accepted Time:
- 2018-04-04 17:18:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1305253 | Eiger Biopharmaceuticals Inc. | EIGR | Biological Products, (No Disgnostic Substances) (2836) | 361004130 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1670138 | Joanne Quan | 350 Cambridge Ave, Suite 350 Palo Alto CA 94306 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-04-02 | 4,000 | $2.06 | 4,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-04-02 | 4,000 | $10.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-04-02 | 4,000 | $0.00 | 4,000 | $2.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
22,256 | 2025-09-22 | No | 4 | M | Direct |
Footnotes
- 25% of the option vested on April 14, 2016 and the remaining shares vest in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date.